Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Net Income: 2023-2024

Historic Net Income for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$65.6 million.

  • Upstream Bio's Net Income fell 110.95% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 113.52%. This contributed to the annual value of -$65.6 million for FY2024, which is 82.59% down from last year.
  • Upstream Bio's Net Income amounted to -$65.6 million in FY2024, which was down 82.59% from -$35.9 million recorded in FY2023.
  • Upstream Bio's 5-year Net Income high stood at -$35.9 million for FY2023, and its period low was -$65.6 million during FY2024.
  • Its 2-year average for Net Income is -$50.8 million, with a median of -$50.8 million in 2023.
  • Data for Upstream Bio's Net Income shows a maximum YoY slumped of 82.59% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Net Income stood at -$35.9 million in 2023, then slumped by 82.59% to -$65.6 million in 2024.